its formulation is included in the australian register of therapeutic goods and its perindopril products have been "a"-flagged on the pbs against the new coversyl arginine salt.
that damage is difficult to quantify.
39 on balance, the burden of the recall in a manner to ensure its success and the numbers of people involved, as well as the possible loss to servier from confusion if servier is subsequently successful outweighs the potential damage to genrx if those stamps that have been distributed remain with the doctors pending the hearing.